Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (404)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
137
4.480
Why?
Vulvar Neoplasms
6
2024
58
2.760
Why?
Carcinoma, Squamous Cell
9
2024
330
2.200
Why?
Carcinoma in Situ
7
2022
73
1.940
Why?
Uterine Neoplasms
10
2023
60
1.940
Why?
Carcinoma, Endometrioid
6
2021
38
1.610
Why?
Adenocarcinoma
10
2024
402
1.550
Why?
Tumor Suppressor Protein p53
3
2024
213
1.480
Why?
PAX2 Transcription Factor
7
2015
22
1.430
Why?
Immunohistochemistry
16
2024
972
1.320
Why?
Uterine Cervical Neoplasms
7
2024
276
1.180
Why?
Ovarian Neoplasms
10
2024
450
1.170
Why?
Observer Variation
4
2024
136
1.130
Why?
Endometrial Hyperplasia
4
2019
14
1.130
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2024
60
1.080
Why?
Stromal Cells
2
2016
72
1.020
Why?
Female
66
2024
26576
0.920
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.890
Why?
Cannabidiol
5
2024
35
0.880
Why?
Myometrium
2
2013
14
0.850
Why?
Endometrium
6
2023
40
0.820
Why?
Adenocarcinoma, Clear Cell
6
2019
34
0.770
Why?
Precancerous Conditions
3
2019
83
0.750
Why?
Aged, 80 and over
20
2024
3138
0.720
Why?
Middle Aged
35
2024
12293
0.700
Why?
Plant Extracts
5
2024
166
0.690
Why?
Cystadenocarcinoma, Serous
4
2013
71
0.690
Why?
Aged
30
2024
9449
0.680
Why?
Humans
69
2024
49929
0.680
Why?
Peripheral Nerves
2
2015
48
0.620
Why?
Mutation
9
2024
1292
0.590
Why?
Placenta
6
2021
129
0.570
Why?
Cervix Uteri
2
2017
42
0.560
Why?
Epithelial-Mesenchymal Transition
2
2016
49
0.560
Why?
Adult
31
2024
13356
0.560
Why?
Cannabis
5
2024
144
0.540
Why?
Adenosarcoma
1
2016
3
0.540
Why?
Polyps
1
2016
20
0.530
Why?
Uterine Cervical Dysplasia
1
2016
49
0.520
Why?
Lymphatic Metastasis
6
2019
226
0.500
Why?
Neoplasm Staging
9
2024
749
0.500
Why?
Fibroma
1
2015
39
0.500
Why?
Papillomavirus Infections
3
2024
167
0.500
Why?
Fallopian Tubes
2
2012
22
0.500
Why?
Tumor Microenvironment
4
2021
221
0.490
Why?
Prognosis
11
2024
1957
0.450
Why?
Neoplasm Invasiveness
6
2019
268
0.440
Why?
Pelvic Neoplasms
1
2011
14
0.390
Why?
Uterus
3
2023
87
0.380
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
75
0.380
Why?
Ejaculatory Ducts
1
2010
3
0.360
Why?
Seminal Vesicles
1
2010
13
0.350
Why?
Neoplasm Recurrence, Local
4
2015
626
0.350
Why?
Spectrum Analysis, Raman
2
2021
54
0.350
Why?
Reproducibility of Results
5
2024
1182
0.350
Why?
Prostate
1
2010
117
0.330
Why?
Bromcresol Purple
1
2009
3
0.330
Why?
Electrophoresis, Capillary
1
2009
9
0.330
Why?
Mice, Inbred C57BL
6
2024
1777
0.320
Why?
Serum Albumin
1
2009
58
0.320
Why?
Human papillomavirus 16
2
2021
44
0.320
Why?
Methionine
2
2020
133
0.310
Why?
beta Catenin
2
2021
101
0.310
Why?
Disease Progression
4
2020
820
0.300
Why?
Predictive Value of Tests
5
2024
907
0.300
Why?
Mice
15
2024
5658
0.300
Why?
Diabetes Mellitus
2
2023
279
0.300
Why?
Genital Neoplasms, Female
2
2018
41
0.290
Why?
Papillomavirus Vaccines
2
2021
67
0.290
Why?
Anus Neoplasms
2
2018
24
0.290
Why?
Cell Proliferation
4
2021
986
0.280
Why?
Metaplasia
2
2019
15
0.280
Why?
Antigens, CD
2
2019
215
0.280
Why?
Diagnosis, Differential
8
2020
1037
0.270
Why?
Prostatic Neoplasms
1
2010
391
0.270
Why?
Colitis
2
2020
51
0.260
Why?
Polyethylene Glycols
2
2017
85
0.260
Why?
Melanoma
2
2020
281
0.260
Why?
Neoplasm Grading
5
2021
123
0.260
Why?
Hypertension
2
2021
531
0.250
Why?
Chi-Square Distribution
2
2016
275
0.250
Why?
Gold
2
2017
129
0.250
Why?
Proteomics
3
2017
292
0.250
Why?
Nanoparticles
2
2017
151
0.240
Why?
Aspartic Acid Endopeptidases
2
2015
16
0.240
Why?
Young Adult
7
2024
4031
0.240
Why?
Retrospective Studies
11
2020
6124
0.230
Why?
Racemases and Epimerases
2
2015
17
0.230
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
3
0.230
Why?
Animals
16
2024
13100
0.230
Why?
Neuroendocrine Tumors
1
2024
22
0.230
Why?
Carcinoma, Neuroendocrine
1
2024
23
0.230
Why?
DNA Mutational Analysis
3
2024
176
0.230
Why?
Head and Neck Neoplasms
2
2019
281
0.230
Why?
Kidney Neoplasms
2
2018
172
0.220
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
40
0.220
Why?
Chlamydia muridarum
1
2024
40
0.220
Why?
Homeodomain Proteins
1
2024
83
0.220
Why?
Lung Neoplasms
2
2019
602
0.220
Why?
Endometriosis
1
2023
14
0.210
Why?
Gynecology
2
2020
49
0.210
Why?
Chlamydia Infections
1
2024
75
0.210
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.210
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.210
Why?
CD4-Positive T-Lymphocytes
1
2024
157
0.200
Why?
Fallopian Tube Neoplasms
2
2012
14
0.200
Why?
Immunotherapy
2
2021
235
0.200
Why?
Gestational Trophoblastic Disease
2
2012
2
0.200
Why?
CTLA-4 Antigen
1
2021
23
0.190
Why?
Genotype
2
2021
539
0.190
Why?
Fetal Membranes, Premature Rupture
1
2021
22
0.190
Why?
Estrogens
2
2023
222
0.190
Why?
Oncogene Fusion
1
2021
4
0.190
Why?
PTEN Phosphohydrolase
3
2020
53
0.190
Why?
Leiomyosarcoma
1
2021
23
0.190
Why?
Diabetes, Gestational
1
2021
51
0.190
Why?
Transcription Factors
3
2020
565
0.190
Why?
Cancer Vaccines
1
2021
78
0.180
Why?
Carcinosarcoma
2
2017
18
0.180
Why?
Infant, Small for Gestational Age
1
2020
32
0.180
Why?
Neoplasms, Experimental
1
2020
111
0.180
Why?
Carcinoma, Papillary
1
2020
49
0.180
Why?
Carcinoma, Transitional Cell
1
2020
52
0.170
Why?
Pregnancy in Diabetics
1
2020
27
0.170
Why?
Colonic Neoplasms
1
2021
158
0.170
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.170
Why?
Carcinoma, Lewis Lung
1
2019
9
0.170
Why?
Radiotherapy
1
2020
124
0.170
Why?
Dermatology
1
2020
52
0.170
Why?
Placenta Diseases
1
2019
14
0.170
Why?
Pregnancy Complications, Neoplastic
1
2019
24
0.170
Why?
Carcinoma, Renal Cell
2
2018
101
0.170
Why?
Skin Diseases
1
2020
114
0.170
Why?
Premature Birth
1
2021
143
0.170
Why?
Hepatic Veno-Occlusive Disease
1
2019
9
0.170
Why?
Odds Ratio
3
2015
548
0.160
Why?
Melanoma, Experimental
1
2019
40
0.160
Why?
Hodgkin Disease
1
2019
44
0.160
Why?
DNA Polymerase II
1
2019
9
0.160
Why?
T-Lymphocytes
1
2021
328
0.160
Why?
DNA Mismatch Repair
1
2019
16
0.160
Why?
Fetal Diseases
1
2019
60
0.160
Why?
Inflammation
2
2020
603
0.160
Why?
Sarcoma
1
2020
65
0.160
Why?
Monocytes
1
2019
131
0.160
Why?
Pregnancy
7
2021
2468
0.160
Why?
Urinary Bladder Neoplasms
1
2020
158
0.160
Why?
Metformin
1
2020
63
0.160
Why?
Methionine Adenosyltransferase
1
2018
19
0.160
Why?
CD8-Positive T-Lymphocytes
1
2019
124
0.160
Why?
Logistic Models
3
2015
896
0.150
Why?
Nuclear Proteins
1
2020
242
0.150
Why?
Disease Models, Animal
6
2020
1411
0.150
Why?
Radiation Tolerance
1
2019
83
0.150
Why?
Hypoglycemic Agents
1
2020
169
0.150
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.150
Why?
Rhabdomyosarcoma
1
2018
12
0.150
Why?
Programmed Cell Death 1 Receptor
1
2018
40
0.150
Why?
DNA Helicases
1
2020
144
0.150
Why?
Hepatocytes
1
2019
179
0.150
Why?
Intestinal Mucosa
2
2020
215
0.150
Why?
Pathology, Molecular
1
2017
22
0.150
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
66
0.150
Why?
Biopsy
5
2020
591
0.150
Why?
Tumor Necrosis Factor-alpha
2
2019
388
0.150
Why?
Liver
3
2024
1106
0.150
Why?
Pregnancy Complications
1
2021
363
0.140
Why?
Osteosarcoma
1
2017
45
0.140
Why?
Neoplastic Cells, Circulating
1
2017
74
0.140
Why?
Gene Expression Profiling
2
2019
1028
0.140
Why?
Vimentin
1
2016
32
0.140
Why?
Time Factors
3
2021
2891
0.130
Why?
Papillomaviridae
1
2017
102
0.130
Why?
Acetaminophen
1
2019
275
0.130
Why?
DNA-Binding Proteins
2
2016
424
0.130
Why?
Oligonucleotide Array Sequence Analysis
1
2017
409
0.130
Why?
Cadherins
1
2016
64
0.130
Why?
Viral Load
1
2016
76
0.130
Why?
Skin Neoplasms
1
2020
487
0.120
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.120
Why?
Neoplasms, Muscle Tissue
1
2015
12
0.120
Why?
Malate Dehydrogenase
1
2014
9
0.120
Why?
Classification
1
2015
14
0.120
Why?
Colposcopy
1
2015
18
0.120
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
17
0.120
Why?
Lipogenesis
1
2014
29
0.120
Why?
Flow Cytometry
1
2017
470
0.120
Why?
World Health Organization
1
2015
48
0.120
Why?
Mice, Inbred BALB C
3
2021
296
0.120
Why?
Cytosol
1
2014
81
0.120
Why?
Histones
1
2016
295
0.120
Why?
Adolescent
4
2024
6417
0.120
Why?
Neoplasm, Residual
1
2015
157
0.120
Why?
Mammary Neoplasms, Experimental
1
2015
121
0.120
Why?
Obesity
1
2022
1096
0.120
Why?
Multiple Myeloma
1
2009
2916
0.120
Why?
High-Throughput Nucleotide Sequencing
3
2021
168
0.110
Why?
Antineoplastic Agents
2
2021
1175
0.110
Why?
Gastrointestinal Tract
1
2014
101
0.110
Why?
Male
10
2024
25454
0.110
Why?
Intestines
1
2014
169
0.110
Why?
Oncogenes
1
2013
57
0.110
Why?
Cell Line, Tumor
4
2020
1388
0.110
Why?
Patient Selection
1
2015
254
0.110
Why?
Clusterin
1
2012
6
0.110
Why?
Membrane Proteins
1
2015
347
0.110
Why?
Risk Factors
3
2015
3605
0.100
Why?
Pancreatic Neoplasms
1
2015
209
0.100
Why?
Histocytochemistry
1
2012
47
0.100
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
22
0.100
Why?
Strongyloidiasis
1
2012
10
0.100
Why?
Follow-Up Studies
2
2016
2177
0.100
Why?
Treatment Outcome
3
2021
5178
0.100
Why?
Cytomegalovirus Infections
1
2012
35
0.100
Why?
Prednisone
1
2012
100
0.100
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
11
0.100
Why?
Vascular Endothelial Growth Factor A
1
2012
183
0.100
Why?
Teratoma
1
2011
25
0.090
Why?
Matrix Metalloproteinases
1
2011
47
0.090
Why?
Adenoma, Oxyphilic
1
2010
11
0.090
Why?
Image Processing, Computer-Assisted
1
2012
242
0.090
Why?
Sensitivity and Specificity
3
2020
858
0.090
Why?
Phenotype
3
2019
728
0.090
Why?
Tissue Array Analysis
3
2015
45
0.090
Why?
Glucocorticoids
1
2012
229
0.090
Why?
Tumor Cells, Cultured
2
2021
462
0.080
Why?
Epigenesis, Genetic
1
2012
370
0.080
Why?
Pregnancy Outcome
2
2021
205
0.080
Why?
Infant, Newborn
3
2021
2729
0.080
Why?
Phosphatidylinositol 3-Kinases
2
2024
139
0.080
Why?
Pilot Projects
2
2023
702
0.080
Why?
Necrosis
2
2024
175
0.080
Why?
Telemedicine
1
2015
465
0.080
Why?
Cell Differentiation
2
2024
649
0.080
Why?
Hysterectomy
2
2021
88
0.080
Why?
Cell Nucleus
2
2021
186
0.070
Why?
Societies, Medical
2
2019
177
0.070
Why?
Host-Pathogen Interactions
2
2021
136
0.070
Why?
Neoplasms
1
2017
1234
0.070
Why?
Gene Expression Regulation
3
2023
964
0.070
Why?
Consensus
2
2020
155
0.070
Why?
Ventricular Pressure
1
2006
16
0.070
Why?
Isoproterenol
1
2006
56
0.070
Why?
Terminology as Topic
2
2018
63
0.070
Why?
Kaplan-Meier Estimate
2
2018
463
0.070
Why?
Serum Response Factor
1
2006
40
0.070
Why?
Combined Modality Therapy
2
2020
638
0.070
Why?
Kidney
1
2010
672
0.070
Why?
Practice Guidelines as Topic
2
2019
458
0.060
Why?
Neoplasm Metastasis
2
2018
235
0.060
Why?
Cytokines
2
2020
607
0.060
Why?
Cells, Cultured
2
2021
1587
0.060
Why?
Proportional Hazards Models
2
2017
404
0.060
Why?
Chromatography, Liquid
2
2016
225
0.060
Why?
Bilirubin
1
2024
40
0.060
Why?
Tandem Mass Spectrometry
2
2016
227
0.060
Why?
Dose-Response Relationship, Drug
2
2019
1354
0.060
Why?
Species Specificity
1
2024
193
0.060
Why?
Heart
1
2006
336
0.060
Why?
Steroids
1
2024
56
0.060
Why?
Th1 Cells
1
2024
53
0.060
Why?
Interleukin-10
1
2024
83
0.060
Why?
Phylogeny
1
2024
234
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2018
824
0.050
Why?
Government Agencies
1
2022
14
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
65
0.050
Why?
Hemorrhage
1
2024
194
0.050
Why?
Choriocarcinoma
2
2012
7
0.050
Why?
Genes, T-Cell Receptor
1
2021
5
0.050
Why?
Uterine Hemorrhage
1
2021
8
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.050
Why?
Parturition
1
2021
49
0.050
Why?
Phthalazines
1
2021
20
0.050
Why?
Remission Induction
1
2021
205
0.050
Why?
Quinazolines
1
2021
32
0.050
Why?
Lymphocyte Activation
1
2021
171
0.050
Why?
Vulva
1
2020
17
0.050
Why?
Taurine
1
2020
14
0.050
Why?
Research Report
1
2020
16
0.050
Why?
Metabolic Networks and Pathways
1
2021
90
0.050
Why?
Herb-Drug Interactions
1
2020
31
0.050
Why?
Mucin-2
1
2020
7
0.040
Why?
Toxicity Tests
1
2020
54
0.040
Why?
Alkaline Phosphatase
1
2020
94
0.040
Why?
Risk
1
2021
314
0.040
Why?
Molecular Targeted Therapy
1
2021
121
0.040
Why?
Piperazines
1
2021
118
0.040
Why?
United States
3
2016
4883
0.040
Why?
Chemokines
1
2020
75
0.040
Why?
Birth Weight
1
2020
104
0.040
Why?
Preoperative Period
1
2020
47
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
579
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
35
0.040
Why?
Endothelium
1
2019
37
0.040
Why?
Colon
1
2020
96
0.040
Why?
Pyrimidines
1
2021
192
0.040
Why?
Mice, Transgenic
2
2014
543
0.040
Why?
Chest Pain
1
2019
55
0.040
Why?
Receptors, Progesterone
1
2020
63
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
31
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
61
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
194
0.040
Why?
Glutamine
1
2020
169
0.040
Why?
Dyspnea
1
2019
74
0.040
Why?
Estrogen Receptor alpha
1
2020
86
0.040
Why?
Liver Function Tests
1
2019
45
0.040
Why?
Fatal Outcome
1
2019
194
0.040
Why?
Mice, Inbred Strains
1
2019
160
0.040
Why?
Drug Synergism
1
2019
152
0.040
Why?
Gestational Age
1
2020
386
0.040
Why?
Imaging, Three-Dimensional
1
2019
152
0.040
Why?
Mice, Nude
1
2019
252
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
212
0.040
Why?
Nephrectomy
1
2018
81
0.040
Why?
Mullerian Ducts
1
2018
4
0.040
Why?
Wolffian Ducts
1
2018
2
0.040
Why?
Mutation Rate
1
2018
36
0.040
Why?
Lymph Node Excision
1
2019
138
0.040
Why?
Ultrasonography, Prenatal
1
2019
160
0.040
Why?
Cell Lineage
1
2018
83
0.040
Why?
Mixed Tumor, Mullerian
1
2017
3
0.040
Why?
DNA Copy Number Variations
1
2018
108
0.040
Why?
Skin
1
2020
415
0.040
Why?
Anal Canal
1
2017
21
0.030
Why?
Macrophages
1
2019
361
0.030
Why?
Dietary Supplements
1
2020
437
0.030
Why?
Transcriptome
1
2019
312
0.030
Why?
Child
2
2024
6849
0.030
Why?
Lymph Nodes
1
2019
257
0.030
Why?
Disease-Free Survival
1
2017
450
0.030
Why?
Matrix Attachment Region Binding Proteins
1
2017
35
0.030
Why?
Telomerase
1
2016
26
0.030
Why?
Vaccines, Subunit
1
2016
15
0.030
Why?
Ontario
1
2016
49
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Diet
1
2020
553
0.030
Why?
Signal Transduction
1
2023
1608
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
82
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
112
0.030
Why?
S100 Proteins
1
2015
34
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
63
0.030
Why?
Cell Count
1
2015
147
0.030
Why?
Cell Hypoxia
1
2015
82
0.030
Why?
Pressure
1
2015
105
0.030
Why?
Drug Evaluation, Preclinical
1
2015
145
0.030
Why?
Blood Vessels
1
2015
71
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
51
0.030
Why?
Genetic Predisposition to Disease
1
2018
508
0.030
Why?
Random Allocation
1
2015
285
0.030
Why?
Immunoenzyme Techniques
1
2014
141
0.030
Why?
Prospective Studies
1
2020
2345
0.030
Why?
Proteome
1
2016
153
0.030
Why?
Radiotherapy Dosage
1
2015
246
0.030
Why?
Apoptosis
1
2020
1092
0.030
Why?
Likelihood Functions
1
2014
54
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
181
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
256
0.030
Why?
Anti-Bacterial Agents
1
2019
742
0.030
Why?
Multivariate Analysis
1
2015
579
0.030
Why?
Vaccination
1
2016
275
0.030
Why?
Genes, erbB-1
1
2013
8
0.030
Why?
Lipid Metabolism
1
2014
175
0.030
Why?
Gene Frequency
1
2013
96
0.030
Why?
Adiposity
1
2014
129
0.030
Why?
SEER Program
1
2013
93
0.030
Why?
Communication
1
2015
247
0.030
Why?
Mesentery
1
2012
32
0.030
Why?
Insulin Resistance
1
2014
255
0.030
Why?
Rural Health Services
1
2015
168
0.030
Why?
Research Design
1
2015
344
0.030
Why?
Diet, High-Fat
1
2014
214
0.030
Why?
Neoplasms, Glandular and Epithelial
1
2012
41
0.030
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.030
Why?
Pregnancy Proteins
1
2012
5
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
6
0.030
Why?
Socioeconomic Factors
1
2015
584
0.030
Why?
Angiopoietin-2
1
2012
15
0.030
Why?
Angiopoietin-1
1
2012
16
0.030
Why?
Ovary
1
2012
114
0.030
Why?
Ivermectin
1
2012
9
0.030
Why?
Antiparasitic Agents
1
2012
10
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
30
0.030
Why?
Infant
1
2020
3575
0.020
Why?
Algorithms
1
2015
613
0.020
Why?
Hydatidiform Mole
1
2011
2
0.020
Why?
RNA, Messenger
1
2014
1099
0.020
Why?
Crohn Disease
1
2012
90
0.020
Why?
Interleukin-6
1
2012
265
0.020
Why?
Isoenzymes
1
2011
168
0.020
Why?
Promoter Regions, Genetic
1
2012
467
0.020
Why?
Gene Expression
1
2012
612
0.020
Why?
Risk Assessment
1
2015
1255
0.020
Why?
Radiography
1
2011
485
0.020
Why?
Cell Line
1
2012
1010
0.020
Why?
Cohort Studies
1
2013
1403
0.020
Why?
DNA Methylation
1
2012
544
0.020
Why?
Rats
1
2014
3273
0.020
Why?
Blotting, Western
1
2006
587
0.020
Why?
Myocardium
1
2006
443
0.010
Why?
Age Factors
1
2006
1092
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description